Wei Zhang Overview

  • Investor Type
  • Angel

  • Investments
  • 5

  • Portfolio
  • 4

  • Exits
  • 1

Exits

Wei Zhang General Information

Description

Mr. Wei Zhang serves as Vice President at Hainan Shuangcheng Pharmaceuticals Co. He also is an Angel Investor.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 16 Xingguo Road
  • Xiuying District
  • Haikou, Hainan 570314
  • China
+86 0898 0000 0000

Wei Zhang Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Venture Space 09-Jul-2018 Early Stage VC Office Services (B2B) Generating Revenue 000 00000
00000 000000 08-Aug-2016 00000 00000 000.00 Pharmaceuticals Profitable 000 00000
0000000 25-Nov-2015 0000 00000 Application Software Startup
FeiBoTong 01-Sep-2015 Angel (individual) 00.000 Automotive Generating Revenue 000 00000
Beijing Chuangxiang Kaixing Science & Trade Co. 01-Aug-2012 Early Stage VC 00000 Other Commercial Services Generating Revenue
To view Wei Zhang’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wei Zhang Exits (1)

Company Name Exit Date Exit Type Exit Size
00000 000000 28-Apr-2020 000 000.00
To view Wei Zhang’s complete exits history, request access »

Wei Zhang Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Wei Zhang Team (1)

Name Title Deals Funds Boards Office
Wei Zhang Angel Investor 0 Haikou, China
To view Wei Zhang’s complete team members history, request access »

Wei Zhang Co-Investors (2)

Name With Exits Lead Partner Series Industry
Gang Mai 1 0 Series chart Industry bar
VenturesLab 0 0 Series chart Industry bar
To view Wei Zhang’s complete co-investors history, request access »